PGNY Progyny

Progyny, Inc. to Present at the BofA Securities 2020 Health Care Conference

Progyny, Inc. to Present at the BofA Securities 2020 Health Care Conference

NEW YORK, May 05, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Pete Anevski, President, Chief Financial and Operating Officer, will participate in a fireside chat at the BofA Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 3:00 P.M. Eastern Time.

A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at

About Progyny

Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians. 

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been named a CNBC 50 Disruptor for three years in a row, to the INC. 5000, Crain’s Fast 50 for NYC, and Modern Healthcare’s Best Places to Work in Healthcare for two years in a row, and Financial Times’ Fastest Growing Companies in the Americas. For more information, visit

For Further Information, Please Contact:

Investors:

James Hart

Media:

Selena Yang

 

EN
05/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progyny

 PRESS RELEASE

New Men’s Health Research from Progyny Challenges Conventional Beliefs...

New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action 75% of men see fertility as an equal gender topic and acknowledge the connection between fertility health and their overall health, yet only 46% of men with a fertility issue have sought support due to stigma, cost, and other barriers. NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: PGNY), a global leader in family building solutions, today announced exploring experiences and views on fertility. The findings shed light on how men in the U.S. view their role in the fertilit...

 PRESS RELEASE

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

Progyny, Inc. to Present at Jefferies Global Healthcare Conference NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Mark Livingston, Progyny’s Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 3:00 p.m. GMT / 10:00 a.m. ET. A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at . About Progyny Progyny (Nasdaq: PGNY) is a global leader in women’...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Progyny, Inc. Announces Third Quarter 2025 Results

Progyny, Inc. Announces Third Quarter 2025 Results Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and Near 100% Retention of Existing BaseRecord $156.0 Million in Operating Cash Flow Generated over the First Nine Months of 2025Board Authorizes Up to $200 Million in Share Repurchase Program NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family buildin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch